Introduction {#s1}
============

The vasculature of the CNS forms an endothelial barrier, not found in other tissues, that limits the flow of molecules and ions between the blood and the brain. This BBB is crucial for maintaining brain homeostasis and for limiting the penetration of toxins and pathogens into the brain [@pone.0013741-Zlokovic1]. The importance of the BBB is highlighted by the severe pathology of diseases in which it is disrupted, including stroke, edema, brain traumas and multiple sclerosis [@pone.0013741-Ballabh1]. The BBB also poses an obstacle for the treatment of neurological disorders as it can greatly limit drug delivery into the brain [@pone.0013741-Pardridge1].

Many of the properties of the BBB are manifested in the endothelial cells which make up the walls of the blood vessels. Endothelial cells in the brain differ from endothelial cells in other tissues in that they are held together by high electrical resistance tight junctions and contain few transcytotic vesicles, limiting the paracellular and transcellular flow of molecules from the blood into the brain [@pone.0013741-Rubin1]. In addition, CNS endothelial cells express a variety of transporters, both to provide the CNS with specific nutrients, and also to efflux potential toxins from the CNS. Whereas the endothelial cells form the barrier, transplantation studies have demonstrated that these properties are not intrinsic to the endothelial cells but signaled by the brain microenvironment [@pone.0013741-Stewart1]. Evidence suggests that the BBB is induced and regulated by its close association with astrocytes, pericytes and other neural cells, however the molecular nature of these interactions remains a mystery [@pone.0013741-Janzer1], [@pone.0013741-Weidenfeller1], [@pone.0013741-Rubin2].

Several studies have taken different approaches to understand the genomics of the BBB, including microarray analysis, subtractive hybridization and serial analysis of gene expression [@pone.0013741-Li1], [@pone.0013741-Li2], [@pone.0013741-Enerson1]. These studies have provided information about the gene expression of CNS vessels but had two limitations. First, because these studies used whole vessel fractions, which contain many different cell types, the transcriptomes of the individual cellular components, the endothelial cells and the pericytes, are not yet known. Second, these studies compared the gene expression of brain vessels with whole tissue fractions instead of purified peripheral vessels. Paramount to understanding the function of the BBB is a comparison of purified endothelial cells from brain with purified endothelial cells from peripheral tissues.

Here we utilize fluorescence-activated cell sorting (FACS) to highly purify endothelial cells from the brain, liver and lung of Tie2GFP transgenic mice [@pone.0013741-Motoike1]. Using Affymetrix microarrays to gene profile these purified cell populations, we have identified a set of genes whose expression is highly enriched at the BBB. These genes include tight junction molecules, transporters, signaling molecules, and other molecule classes. This analysis has implicated Wnt and RXRalpha signaling cascades in regulating this crucial barrier.

Materials and Methods {#s2}
=====================

Ethics Statement {#s2a}
----------------

All experiments were approved by Stanford University IACUC committee, approved protocol \#10726.

FACS purification of GFP^+^ cells {#s2b}
---------------------------------

Homozygous Tie2GFP mice (strain 003658) were obtained from Jackson labs and bred to maintain homozygosity. Cell suspensions were prepared from cerebral cortex, liver or lung based on procedures previously described [@pone.0013741-Huettner1], [@pone.0013741-Cahoy1]. For brain samples, the cerebral cortex was dissected away from the forebrain, then the meninges were peeled off with fine forceps. For liver samples, peripheral regions of each lobe were utilized to avoid the hepatic portal vein ensuring the tissue vasculature consisted primarily of capillaries. Whole lung lobes were utilized. Each tissue was diced with a scalpel, and enzymatically dissociated with a papain solution (40 U/ml Worthington-3126) containing L-cysteine (0.4 mg/ml, Sigma C 7477) and DNase (125 U/ml, Worthington LS002007) for 1.5 hours at 35°C, prior to mechanical trituration in a solution containing ovomucoid (2 mg/ml, Roche 109878), DNase (125 U/ml) and BSA (1 mg/ml, Sigma A8806), to yield a cell suspension, which was recovered by centrifugation. Cell suspensions were re-suspended in FACS buffer (DPBS, 0.02%BSA with propidium iodide), and endothelial cells were FACS purified based on GFP fluorescence utilizing a FACS Vantage SE sorter (Becton Dickinson) and CellQuest software. For each tissue, background GFP fluorescence was determined by FACS analysis of cell suspensions from wild type FvB mice (Charles River), and dead cells were eliminated by high propidium iodide fluorescence. Forward scatter and side scatter analysis were also used as gates to limit the sorting to single live cells. For additional pericyte/VSM depletion, cell suspensions were stained with a goat anti-mouse PDGFRbeta primary antibody (R & D systems), and a donkey anti-goat secondary antibody labeled with APC. For these experiments, background APC fluorescence was gated with cell suspensions incubated with secondary, but not primary antibody. In each case, two rounds of sorting were performed for maximal purity, based on reanalysis. Cortical GFP^−^ cells were isolated from Tie2GFP^+^ mice with gating based on background GFP fluorescence from wild type FvB mice.

GeneChip Analysis {#s2c}
-----------------

Purification of RNA, generation of biotinylated cRNA, subsequent hybridization to Affymetrix Mouse Genome 430 2.0 Arrays and raw image analysis with Affymetrix GCOS 1.3 software was performed as previously described [@pone.0013741-Cahoy1]. Three biological replicates were used for each analysis of adult cells, whereas five biological replicates were utilized for postnatal samples. Each biological replicate represents a purification from different mice performed on different days. The Significance Analysis of Microarrays (SAM) method was used to determine genes that were significantly different between cell populations. For this analysis, samples were grouped into 6 groups: brain parenchyma (GFP^−^), brain vascular (GFP^+^), brain endothelial (GFP^+^PDGFRbeta^−^), postnatal brain GFP^+^, liver endothelial and lung endothelial. Probe sets were included in this statistical analysis if they were defined as being called present and having an intensity level greater than 200 in at least two-thirds of the samples in at least one group. The significance thresholds were set for a false discovery rate of less than 1% with a fold-change of greater than 2.0×. For each data analysis presented in this paper, fold-enrichment was calculated as expression value of one data set divided by the second. In each table presented, probe sets were included only if gene expression was ≥200 in the enriched data set. In comparisons of brain endothelial to lung and liver endothelial samples, or comparisons of adult and postnatal brain samples, GFP^+^ samples for each tissue were compared, and CNS pericyte/VSM enriched transcripts (brain GFP^+^/GFP^+^PDGFRbeta^−^\>2) were excluded. To identify signaling and metabolic pathways enriched in specific data sets, Ingenuity Pathway Analysis software core analysis (Ingenuity systems) was utilized to determine the statistical significance of enrichment for the pathways within a given data set.

*In situ* Hybridization {#s2d}
-----------------------

*In situ* hybridization on P20 fresh frozen mouse brain and liver sections was performed as described [@pone.0013741-SchaerenWiemers1] with a few modifications, omitting the treatment with Proteinase K. The antisense mRNA probes were generated using the DIG RNA Labeling Kit (Roche Applied Science, Indianapolis, IN). Ten genes were analyzed by *in situ* hybridization on P20 fresh frozen mouse brain and liver sections: Pecam (*Sma*I, T7), Cldn5 (*Xho*I, T3), Apcdd1 (*HindIII*, T7), Abcb1a (*EcoR*V, T7), Slco1c1 (*Xho*I, T3), Slco1a4 (*XhoI*, T3), Slc22a8 (*Xho*I, T3), Slc7a5 (*SalI*, T3), Itih5 (*Sal*I, T3), Foxq1 (*EcoR*V, T7). Apcdd1 cDNA was amplified by RT-PCR using total RNA isolated from FACS isolated Tie2GFP P60 brain endothelial cells. The other full length or partial cDNAs were obtained as mouse ESTs from Open Biosystems (Hunstville Al).

Results {#s3}
=======

Purification of CNS Vascular Cells from Tie2GFP Mice {#s3a}
----------------------------------------------------

To purify cells from the vasculature of different tissues we took advantage of Tie2GFP transgenic mice available from Jackson labs. These mice express the green fluoresecent protein (GFP) under the pan-endothelial Tie2 promotor, and GFP fluorescence can be visualized in the vasculature of the brain, liver, lung, spleen, kidney, muscle and other tissue cryosections ([Figure 1a](#pone-0013741-g001){ref-type="fig"})[@pone.0013741-Motoike1]. When single cell suspensions of adult cerebral cortex were analyzed by FACS, approximately 5% of the cells were GFP^+^, a figure which matches the proportion of vascular cells in the brain ([Figure 1b](#pone-0013741-g001){ref-type="fig"})[@pone.0013741-Motoike1]. Using a double FACS procedure to ensure the highest purity ([Figure 1b](#pone-0013741-g001){ref-type="fig"}) we purified three different cell populations: GFP^−^ (parenchymal), GFP^+^ (vascular cell), and GFP^+^PDGFRbeta^−^ (endothelial cell). For the latter cell population an anti-PDGFRbeta depletion step was utilized to deplete pericytes/vascular smooth muscle cells (VSMs) from the sample.

![Purification of endothelial cells from the cerebral cortex of Tie2GFP mice.\
A) GFP is expressed in the vasculature of Tie2GFP transgenic mice. GFP (green) can be visualized in a vascular pattern in tissue cryosections of cerebral cortex of an adult Tie2GFP transgenic mouse. Nuclei were stained with DAPI (blue). Bar, 50 microns. B) FACS purification of GFP^+^ cells from the cerebral cortex of Tie2GFP mice. Single cell cortical suspensions were sorted for GFP fluorescence twice, isolating a GFP^+^ cell population that is greater than 99.3% pure. Y-axis represents side scatter co-efficient, X-axis represents GFP fluorescence, numerical values represent percent of total cells sorted that are within gated region. C) Purity of FACS sorted cells. GeneChip transcriptional profiling of GFP^−^ (parenchyma), GFP^+^ (vascular) and GFP^+^PDGFRbeta^−^ (endothelial) fractions from the cerebral cortex of Tie2GFP mice. Neuronal, astrocyte, oligodendrocyte, microglial, endothelial and pericyte markers were analyzed to detect the purity of sample for each FACS sorted sample. The GFP^+^ sample contains a mixture of endothelial cells and pericytes, such that an additional PDGFRbeta negative selection is needed to generate a pure endothelial cell population. Error Bars represent standard error of the mean (SEM).](pone.0013741.g001){#pone-0013741-g001}

The purity of these cell populations was ascertained by using Affymetrix microarrays to compare the relative mRNA levels of specific markers for neurons (synaptotagmin I, synaptophysin, neuronal enolase), astrocytes (GFAP, Aq4, s100beta), oligodendrocyte lineage cells (MBP, MAG, MOBP), microglial cells (cd68, Ptprc), endothelial cells (Tie2, claudin 5, and Flt1) and pericytes/VSMs (PDGFRbeta, Abcc9, and Kcnj8) ([Figure 1c](#pone-0013741-g001){ref-type="fig"}). As expected, the neuronal and glial markers were all present in the brain parenchyma sample and low to absent in the vascular and endothelial cell samples, indicating these samples did not contain neural cells. The vascular cell sample contained endothelial and pericyte/VSM cell markers indicating it was a mixture of these two cell populations, whereas the endothelial cell sample contained endothelial cell markers but not pericyte/VSM markers. This separation allowed us to purify endothelial cells and identify the endothelial cell transcriptome. Furthermore, comparing the vascular and endothelial cell data sets we are able to identify many genes that are highly enriched to pericytes/VSM. A master data table of all data sets described can be found in [Table S1](#pone.0013741.s001){ref-type="supplementary-material"}.

In [Table S2](#pone.0013741.s002){ref-type="supplementary-material"}, we list the enriched CNS endothelial genes, defined as those GeneChip probe sets significantly enriched greater than two-fold in the endothelial:parenchymal fractions (GFP^+^ PDGFRbeta^−^:GFP^−^). We further present a list of the pericyte/VSM enriched genes, as defined as enriched greater than two-fold in the Vascular:Endothelial (GFP^+^:GFP^+^PDGFRbeta^−^) fractions ([Table S3](#pone.0013741.s003){ref-type="supplementary-material"}). In [Table 1](#pone-0013741-t001){ref-type="table"} we list the most endothelial and pericyte enriched probe sets which provide many new endothelial and pericyte/VSM specific markers within the brain.

10.1371/journal.pone.0013741.t001

###### Most enriched CNS endothelial and pericyte transcripts.

![](pone.0013741.t001){#pone-0013741-t001-1}

  A.Probe Set ID     Gene Symbol    Brain Endothelial/Parenchyma   B.Probe Set ID    Gene Symbol    Vascular/Endothelial
  ---------------- --------------- ------------------------------ ---------------- --------------- ----------------------
  1421078_at            Tcf23                   96.1                 1423341_at         Cspg4               40.9
  1438558_x\_at         Foxq1                   71.9                 1418773_at         Fads3               38.8
  1422905_s\_at         Fmo2                    62.1               1455098_a\_at         Vtn                32.7
  1460371_at           Hspa12b                  62.1                 1416286_at         Rgs4                27.8
  1438227_at             She                    59.4               1437902_s\_at       Rarres2              27.1
  1436939_at           Unc45b                   55.4               1459713_s\_at       Tmem16a              25.8
  1419467_at           Clec14a                  52.4                 1425103_at         Ace2                24.6
  1448117_at            Kitl                    52.3                 1433525_at         Ednra               24.3
  1447933_at           Kif26a                   52.0                 1426285_at         Lama2               22.2
  1438325_at            Evi1                    51.3                 1434141_at        Gucy1a3              22.0
  1422966_a\_at         Tfrc                    48.3                 1417439_at         Cd248               21.9
  1416564_at            Sox7                    48.0                 1448649_at         Enpep               21.6
  1443832_s\_at         Sdpr                    47.9                 1417148_at        Pdgfrb               20.1
  1438532_at            Hmcn1                   47.7               1438658_a\_at        Edg3                20.0
  1449184_at           Pglyrp1                  47.6                 1436411_at        Atp13a5              20.0
  1452352_at           Ctla2b                   44.8                 1438751_at       Slc30a10              19.6
  1435701_at            Cyyr1                   44.8                 1427221_at        Xtrp3s1              18.9
  1436419_a\_at     1700097N02Rik               44.2               1448421_s\_at        Aspn                18.2
  1449328_at            Ly75                    42.0                 1418142_at         Kcnj8               17.7
  1428345_at           Ppapdc2                  42.0               1436203_a\_at    1110059G02Rik           16.4
  1442698_at            \-\--                   41.1                 1435751_at         Abcc9               16.3
  1440926_at            Flt1                    40.8                 1424186_at        Ccdc80               15.4
  1456061_at           Gimap8                   40.7               1452474_a\_at        Art3                15.2
  1452013_at           Atp10a                   40.6                 1424902_at        Plxdc1               15.0
  1418059_at            Eltd1                   39.6                 1424733_at        P2ry14               14.6
  1438587_at        4933417M04Rik               39.3                 1455050_at     E130203B14Rik           14.3
  1441907_s\_at         Cd93                    38.9                 1423477_at         Zic1                13.3
  1440225_at           Gpr116                   38.8                 1448918_at        Slco3a1              13.1
  1451500_at           Ushbp1                   38.7                 1448132_at        Slc19a1              12.8
  1456152_at            Paqr5                   38.6               1437165_a\_at       Pcolce               12.8
  1447584_s\_at         Myct1                   37.8               1448123_s\_at        Tgfbi               12.5
  1459888_at          LOC545261                 37.6                 1455271_at       LOC620695             12.5
  1422028_a\_at         Ets1                    37.0                 1417011_at         Sdc2                12.4
  1457867_at            Sgpp2                   36.9                 1434893_at        Atp1a2               12.4
  1417616_at         St6galnac2                 36.8                 1440879_at         Abca9               11.9
  1418979_at           Akr1c14                  36.5               1430700_a\_at       Pla2g7               11.7
  1420459_at            Dscr6                   36.4                 1424099_at     2310016C16Rik           11.7
  1438027_at        5830443L24Rik               35.8                 1422058_at         Nodal               11.7
  1457141_at            Aqp11                   35.7                 1417534_at         Itgb5               11.6
  1416832_at           Slc39a8                  35.6                 1419663_at          Ogn                10.1
  1429177_x\_at         Sox17                   35.3                 1422545_at         Tbx2                10.1
  1456768_a\_at         Mmrn2                   35.0                 1420872_at        Gucy1b3              10.0
  1444181_at           Gimap5                   35.0                 1435741_at         Pde8b               9.9
  1419758_at           Abcb1a                   34.7                 1454966_at         Itga8               9.8
  1426914_at          Marveld2                  34.5                 1449860_at        Higd1b               9.4
  1432176_a\_at          Eng                    34.3                 1416271_at         Perp                8.8
  1439221_s\_at         Cd40                    34.2               1420688_a\_at        Sgce                8.7
  1448862_at            Icam2                   33.6                 1430136_at         Grm3                8.2
  1448471_a\_at        Ctla2a                   33.3                 1435805_at         Lin7a               8.0
  1435418_at           Slc22a8                  33.0                 1418157_at         Nr2f1               7.6

A\) Most enriched CNS endothelial transcripts. List of the 50 most enriched endothelial cell transcripts defined as the greatest ratio of brain endothelial cell (GFP^+^ PDGFRbeta^−^): brain parenchyma (GFP^−^) values analyzed by affymetrix GeneChips.

B\) Most enriched CNS pericyte transcripts. List of the 50 most enriched pericyte transcripts defined as the greatest ratio of brain vascular (GFP^+^): brain endothelial (GFP^+^ PDGFRbeta^−^) values analyzed by Affymetrix GeneChips.

Identification of the Blood-Brain Barrier Transcriptome {#s3b}
-------------------------------------------------------

In order to identify blood-brain barrier enriched transcripts, we next utilized GeneChip analysis to compare the gene expression in GFP^+^ cells isolated from the brain, liver and lung of adult Tie2GFP mice. In each case, we used a double FACS purification procedure in order to isolate GFP^+^ cells for maximal purity. Comparison of the gene profiles of brain and liver, or brain and lung, revealed that the GFP^+^ cell populations in these tissues were very similar. This is graphically represented by a dot plot, in which each dot represents a probe set on the Affymetrix GeneChip, and their position relative to the logarithmic X and Y axes represents expression levels in the different tissues analyzed ([Figure 2a](#pone-0013741-g002){ref-type="fig"}). In these analyses, the vast majority of genes lie near the diagonal axis, indicating that their expression levels are not more than two-fold different between the samples compared. There are, however, outliers, genes which are expressed at vastly different levels in the vasculature of the different tissues. These differences were not identified between two biological replicates of brain GFP^+^ cells ([Figure 2a](#pone-0013741-g002){ref-type="fig"}). Furthermore, far greater variation was observed between the transcriptional profile of brain endothelial cells and those for neurons and glia ([Figure 2a](#pone-0013741-g002){ref-type="fig"}, data for neurons and glia generated by Cahoy et al 2008). The genes which are expressed at high levels in the brain vasculature, but low or absent from the liver and lung, are BBB-enriched genes. For BBB-enriched genes we identify genes that are enriched in the Brain GFP^+^ (vascular) cells, compared to liver GFP^+^ cells and lung GFP^+^ cells, and eliminate any pericyte enriched genes by comparing Brain GFP^+^PDGFRbeta^−^ endothelial cells with Brain GFP^+^ vascular cells. Preliminary validation of this data set comes from analyzing characterized endothelial genes. For instance, known pan-endothelial genes, including Tie2, PECAM1 and claudin 5, are expressed at similar levels in all tissue data sets, whereas established BBB-specific genes glut-1, p-glycoprotein, occludin and the transferrin receptor, are expressed at significantly higher levels in the brain vasculature than the liver or lung ([Figure 2b](#pone-0013741-g002){ref-type="fig"}). To further validate our data set we used *in situ* hybridization to analyze the expression pattern of the several top brain endothelial transcripts enriched compared with liver (Itih5, Apcdd1, Abcb1a and Slco1c1) and lung endothelial cells (Slc22a8, Slc7a5, Slco1a4 and Foxq1) ([Figure 3](#pone-0013741-g003){ref-type="fig"}). In each case, we observed expression in vascular cells in the brain but not liver. Interestingly, the pattern observed was different between the probe sets tested. For instance, Itih5 and Foxq1 appeared to be expressed sporadically and specifically in larger vessels, whereas Apcdd1, Slco1a4 and Slc22a8 appear to be expressed in smaller vessels. Indeed, hetereogeneity between the different segments of the CNS vasculature has been observed[@pone.0013741-Macdonald1], and specific transcripts may be differentially expressed between arteries, arterioles, capillaries, venules and veins.

![Comparison of transcriptional profiles of brain endothelial cells with liver and lung endothelial cells.\
A) Affymetrix GeneChips were utilized to compare gene expression in GFP^+^ cells isolated from cerebral cortex, liver and lung of Tie2GFP transgenic mice. The data is represented as a dot plot on a logarithmic scale, where each point reflects a probe set on the GeneChip. Black dots indicate probe sets identified as present in both samples, red dots indicate probe sets identified as present in the brain but not peripheral sample, blue dots indicate probe sets present in the peripheral but not brain sample, and grey dots represent probe sets identified as absent in both samples. Two biological replicates of the brain GFP^+^ samples were compared to identify variation between replicates. In addition, brain GFP^+^ cells were compared with profiles generated for neurons and glia by Cahoy et al (2008). Black diagonal lines represent cutoffs for two-fold, four-fold and eight-fold differences. B) Validation of transcriptional profiling by comparison of GeneChip expression with known CNS endothelial markers. Expression values are given relative to the brain GFP^+^ sample. Pan endothelial transcripts are expressed in all GFP^+^ samples, whereas BBB transcripts were enriched in the Brain GFP^+^ sample. Error bars represent SEM.](pone.0013741.g002){#pone-0013741-g002}

![Selective expression of blood-brain barrier-enriched genes in CNS endothelial cells.\
Expression of *Pecam* (A, B), *Cldn5* (C, D), *Apcdd1* (E, F), *Abcb1a1* (G, H), *Slco1c1* (I, J), *Slco1a4* (K, L), *Slc22a8* (M, N), *Slc7a5* (O, P), *Itih5* (Q, R) and *Foxq1* (S, T) mRNA in the brain and liver of P20 mouse pups. The top four brain endothelial transcripts enriched compared with liver (Itih5, Apcdd1, Abcb1a and Slco1c1) and lung endothelial cells (Slc22a8, Slc7a5, Slco1a4 and Foxq1) were analyzed, excluding transcripts also expressed in the brain parenchyma (brain GFP^+^:brain GFP^−^\<2), and those expressed at \<10000 to ensure that the signal would be above the detection limit of the *in situ* hybridization. Note that *Pecam1 and Cldn5* mRNAs are expressed in the endothelial cells in both brain and liver. However, the transcripts for the blood-brain barrier enriched genes are only present in brain but not liver endothelial cells. Bar, 200 microns.](pone.0013741.g003){#pone-0013741-g003}

From this analysis, we conclude that we have generated a comprehensive data set representing the blood-brain barrier transcriptome. In [Table 2](#pone-0013741-t002){ref-type="table"} we list the most BBB enriched genes: those with the greatest difference between expression levels in the brain GFP^+^ cells versus liver and lung GFP^+^ cells, with parenchymal and pericyte/VSM transcripts excluded from these lists. All BBB enriched genes are listed in [Table S6](#pone.0013741.s006){ref-type="supplementary-material"}. In addition to identifying BBB enriched transcripts, we can also use this data set to identify genes which are enriched in the liver and lung endothelial cells compared with brain endothelial cells ([Table S7](#pone.0013741.s007){ref-type="supplementary-material"}). These genes might be important for regulating the permeability of non-CNS vessels, or imparting specific functions of non-CNS endothelial cells. In the following sections we present functional subsets of BBB enriched genes including tight junction proteins, transporters, signaling molecules and metabolic pathways that together constitute the blood-brain barrier.

10.1371/journal.pone.0013741.t002

###### Most BBB enriched transcripts.

![](pone.0013741.t002){#pone-0013741-t002-2}

  A.Probe Set ID     Gene Symbol    Brain/Liver   Brain/Lung   B.Probe Set ID    Gene Symbol    Brain/Liver   Brain/Lung
  ---------------- --------------- ------------- ------------ ---------------- --------------- ------------- ------------
  1441946_at            Itih5         3124.8        213.3        1418706_at        Slc38a3         85.5         821.1
  1449070_x\_at        Apcdd1         3087.4         75.2        1435418_at        Slc22a8         774.6        764.3
  1419758_at           Abcb1a         1848.7         12.9        1418326_at        Slc7a5          15.8         734.2
  1423343_at           Slco1c1        1745.2        310.2        1420405_at        Slco1a4         847.4        450.2
  1437967_at            Titin          948.1         63.9        1423424_at         Zic3           438.5        441.2
  1448147_at          Tnfrsf19         908.6         18.9      1438558_x\_at        Foxq1          317.0        404.8
  1420405_at           Slco1a4         847.4        450.2        1423343_at        Slco1c1        1745.2        310.2
  1447787_x\_at         Gja7           825.5         3.8         1428223_at         Mfsd2          777.8        224.9
  1428223_at            Mfsd2          777.8        224.9        1441946_at         Itih5         3124.8        213.3
  1435418_at           Slc22a8         774.6        764.3        1426215_at          Ddc           142.0        171.7
  1418094_s\_at         Car4           772.1         2.9         1434734_at     E130016E03Rik      168.2        167.1
  1419700_a\_at         Prom1          589.5         69.8        1453072_at        Gpr160          10.8         165.4
  1429154_at           Slc35f2         552.5         69.2        1415802_at        Slc16a1         59.3         148.3
  1447272_s\_at        Atp10a          527.2         42.8        1442347_at         Lrp8           387.2        145.4
  1429348_at           Sema3c          511.0         1.3         1449184_at        Pglyrp1         371.8        116.0
  1448557_at        1200015N20Rik      481.7         10.9        1454734_at         Lef1           89.5         108.6
  1428663_at        5133401H06Rik      472.0         4.8         1436417_at        Slc19a3         249.7        105.8
  1425779_a\_at         Tbx1           469.4         25.2        1426399_at         Vwa1           202.8        103.8
  1423424_at            Zic3           438.5        441.2        1418383_at        Apcdd1          448.3         95.6
  1457867_at            Sgpp2          429.8         9.3         1460459_at         Paqr5          72.3          80.2
  1460465_at        A930038C07Rik      419.3         9.8         1439609_at         \-\--          116.6         70.8
  1423608_at            Itm2a          415.0         25.3      1419700_a\_at        Prom1          589.5         69.8
  1451255_at         MGI:1927471       412.6         41.0        1451047_at         Itm2a          266.5         69.5
  1427157_at        E030025D05Rik      390.4         0.8         1429154_at        Slc35f2         552.5         69.2
  1442347_at            Lrp8           387.2        145.4        1437967_at         Titin          948.1         63.9
  1416301_a\_at         Ebf1           380.1         11.8      1423858_a\_at       Hmgcs2          63.9          62.7
  1425415_a\_at        Slc1a1          372.5         12.5        1417061_at        Slc40a1          1.1          59.2
  1449184_at           Pglyrp1         371.8        116.0        1452661_at         Tfrc           48.1          55.4
  1439505_at            Clic5          357.9         0.9         1435123_at     C030014M07Rik      52.6          52.2
  1426431_at            Jag2           325.6         4.4         1424549_at         Degs2          156.4         50.0
  1438558_x\_at         Foxq1          317.0        404.8        1456140_at         Zic5           61.5          48.7
  1448117_at            Kitl           261.9         1.2       1426599_a\_at       Slc2a1          234.7         48.5
  1448873_at            Ocln           255.5         9.8       1417714_x\_at       Hba-a1           5.2          47.7
  1438452_at            Nebl           253.1         4.7       1427931_s\_at        Pdxk           31.0          43.7
  1437360_at           Pcdh19          249.8         19.4      1447272_s\_at       Atp10a          527.2         42.8
  1436417_at           Slc19a3         249.7        105.8        1451255_at          Lsr           412.6         41.0
  1454622_at           Slc38a5         237.6         13.5        1435026_at        Spock2          180.3         37.7
  1426599_a\_at        Slc2a1          234.7         48.5        1456147_at        st8sia6         95.7          36.9
  1433933_s\_at        Slco2b1         226.7         18.5      1426082_a\_at       Slc16a4         94.0          34.0
  1418412_at           Tpd52l1         216.4         25.6        1417022_at        Slc7a3          38.6          33.0
  1454795_at           Cobll1          216.0         5.9         1435465_at        Kbtbd11         129.9         30.5
  1426399_at            Vwa1           202.8        103.8      1456616_a\_at         Bsg           24.7          30.1
  1452968_at           Cthrc1          200.9         7.2         1452202_at         Pde2a           0.7          30.1
  1459903_at           Sema7a          194.3         4.2       1417184_s\_at        Hbb-b           3.0          29.0
  1418979_at        9030611N15Rik      182.3         9.9         1442698_at         \-\--           5.7          28.5
  1435026_at           Spock2          180.3         37.7        1437268_at        Lancl3          53.2          28.0
  1434734_at           Rad54b          168.2        167.1        1418412_at        Tpd52l1         216.4         25.6
  1437479_x\_at         Tbx3           163.6         1.8         1429206_at        Rhobtb1          2.7          25.4
  1424549_at            Degs2          156.4         50.0      1451675_a\_at        Alas2           6.1          25.4
  1426215_at             Ddc           142.0        171.7      1451857_a\_at    5730593N15Rik      31.2          25.3

The 50 most enriched transcripts in brain GFP^+^ cells compared with (A) liver, or (B) lung. Fold-enrichment given as a ratio of brain GFP^+^: peripheral GFP^+^ microarray expression values. To highlight BBB enriched transcripts, only probe sets ≥ two-fold enriched in brain endothelial cells compared with brain parenchyma (GFP^-^) are listed, and pericyte genes are excluded.

Identification of Novel BBB Enriched Tight Junction Molecules {#s3c}
-------------------------------------------------------------

Tight junctions (TJs) are crucial components of the blood-brain barrier [@pone.0013741-Gloor1], but many of the key molecules that constitute these junctions are not yet known. In [Table 3](#pone-0013741-t003){ref-type="table"}, we list the tight junction transcripts expressed by brain endothelial cells, and their relative expression levels in liver and lung endothelial cells. Among the claudin gene family, claudin 5 and claudin 12 are expressed by endothelial cells in all tissues, as described in the literature [@pone.0013741-Morita1], [@pone.0013741-Nitta1]. Claudin 1, 3, and 11 have also been suggested to be expressed at the BBB [@pone.0013741-Enerson1], [@pone.0013741-Lee1], [@pone.0013741-Hawkins1], however, we did not see a definitive signal for any of these molecules. We also did not see expression of these molecules in CNS vessels by mRNA *in situ* hybridization and immunofluoresence imaging (data not shown), suggesting that claudin 5 and 12 are the key claudins expressed at the BBB. Whereas these endothelial claudins are expressed by endothelial cells in all tissues analyzed, we found that other tight junction transmembrane molecules including occludin, marveld2 (tricellulin), and Jam4 are highly enriched in brain endothelial cells. The specific expression of occludin at the BBB has been well documented [@pone.0013741-Hirase1], however, the enrichment of Jam4 and marveld2 in CNS endothelial cells is a novel finding. Marveld2 functions to seal tight junctions at points where three cells meet [@pone.0013741-Riazuddin1], [@pone.0013741-Ikenouchi1]. The expression of this molecule by brain endothelial cells suggests that sealing tripartite adhesions may be critical for forming a high electrical resistance barrier. Endothelial cells of BBB capillaries form TJs with adjacent endothelial cells, as well as intra-cellular junctions as they fold over on to themselves forming the vessel tube. Thus, tripartite adhesions at the BBB could be the interface between intercellular tight junction strands and intracellular tight junction strands.

10.1371/journal.pone.0013741.t003

###### BBB enriched tight junction molecules.
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  Probe set                      Gene Symbol   Brain GFP+   Liver GFP+   Lung GFP+
  ----------------------------- ------------- ------------ ------------ -----------
  **Transmembrane Molecules**                                           
  1417839_at                        Cldn5       38079.1      15781.7      25539.9
  1433781_a\_at                    Cldn12        1728.6       1554.1      2732.0
  1448873_at                        Ocln        10303.7        40.3       1054.4
  1451407_at                        Jam4         1053.1        21.9        219.6
  1436568_at                        Jam2        11440.3      11372.0      3897.8
  1426914_at                      Marveld2       2877.8        72.7        554.4
  **Cytoplasmic Adaptors**                                              
  1450985_a\_at                     Tjp2         9089.6       3809.5      9019.6
  1417749_a\_at                     Tjp1        25536.7      14771.9      16378.3
  1426691_at                        Tjap1        509.3        588.0        572.8
  1455179_at                        Mpp7         787.1        195.1        436.3
  1434954_at                        Mpp5         1197.4       1166.8       884.7
  1450919_at                        Mpp1         1438.7       3789.9      1506.7
  1435461_at                        Magi3        3487.4       1785.9      2131.1
  1452309_at                        Cgnl1        8039.7       430.1       1562.4
  1415691_at                        Dlg1         3574.6       2188.6      3425.2
  1426465_at                       Dlgap4        773.3        1219.4      1842.6
  1427064_a\_at                     Scrib        551.2        605.5        625.0
  1420851_at                       Pard6g        1176.7       426.6       4731.0
  1434775_at                        Pard3        2325.2        62.8       1465.7
  1450937_at                        Lin7c        2913.0       2055.6      2396.9
  1424595_at                        F11r         4332.0       5220.9      4775.5
  1460356_at                        Esam1       21470.6      16937.8      15387.4
  1433956_at                        Cdh5         2893.8       4790.3      6622.2
  1420985_at                        Ash1l        2011.1       1239.5      2094.6
  1426623_a\_at                   Arhgap17       845.4        1530.9       891.0
  1452387_a\_at                    Amotl2        2714.8       5359.0      2375.6
  1428785_at                       Amotl1        1989.5       6058.1      2486.1
  1454890_at                        Amot         5943.5       3708.8       835.5
  1433676_at                        Wnk1        15543.9      10052.6      12021.5

Transcripts defined by MGI as tight junction molecules, or related family members, expressed in brain GFP^+^ cells with an expression value ≥500 by Affymetrix GeneChip analysis. Transcripts highlighted in red are enriched at least 3-fold over liver endothelial cells.

Several intracellular accessory tight junction molecules are also expressed in all endothelial cells. These include ZO-1, ZO-2, Mpdz, MPP1, MPP5, MPP6, MPP7, Dlgh1, Dlgh5, Dlgap4, lglh and Scrib. These proteins may play integral roles in linking the tight junction to the actin cytoskeleton as well as regulating the function of the junctions. However, they are expressed by all endothelial cells, and therefore their presence alone does not define the BBB. In our data set we have also identified several interesting cytoplasmic tight junction molecules as being highly enriched at the BBB, including cingulin-like 1 (jacop) and pard3. Cingulin-like 1 is also of great interest as it is homologous to cingulin, which links tight junctions to the actin cytoskeleton [@pone.0013741-Ohnishi1]. Perhaps the difference between peripheral and CNS endothelial cells is not the expression of the structural claudins, but in how claudins are regulated by the cytoskeleton. The pard family molecules are highly conserved throughout evolution from worms to flies to mammals and are involved in the formation of asymmetry in cells during development [@pone.0013741-Suzuki1], [@pone.0013741-Macara1]. This is very interesting as a defining feature of blood-brain barrier forming endothelial cells is that the tight junctions form highly asymmetric cells, and that different transporters are localized specifically to the luminal or abluminal surface [@pone.0013741-Cornford1].

In each case, the BBB enriched TJ molecules identified, whether occludin, marveld2, jam4, cingulin-like 1, or pard3, all have far greater expression levels in the brain endothelial cells than liver endothelial cells, with lung endothelial cells expressing at intermediate levels. This pattern follows the known level of permeability of the vessels in each tissue. BBB vessels form a tight impermeable barrier, liver sinusoidal capillaries are among the leakiest vessels in the body, whereas lung vessels have an intermediate permeability [@pone.0013741-Aird1], [@pone.0013741-Aird2]. The fact that the expression levels of enriched tight junction molecules follows this pattern suggests that we may be able to identify novel molecules involved in barrier function by examining our data set for probe sets whose expression level increases in the liver GFP^+^ to lung GFP^+^ to brain GFP^+^ microarray analyses. These quantitative profiles should be highly useful for identifying candidate genes that may regulate the differential permeability observed in blood vessels of various tissues throughout the body. With this in mind, novel molecules that follow a similar pattern may also be important for BBB formation. A number of these molecules are known to associate with cellular junctions in other tissues including Sorbs1, Sorbs2, Enah, Neo1 and Lims2, and thus may be important for BBB formation [@pone.0013741-Zhang1], [@pone.0013741-Zhang2], [@pone.0013741-Srinivasan1], [@pone.0013741-Hoffman1], [@pone.0013741-Kioka1]. In addition we may be able to identify novel transmembrane molecules involved in structural adhesions. Intriguing candidates are Itm2a, Apcdd1, Tmeff1, Tmem23, Ly75, Ly6c, cd34, Pcdh19 and Extl3. Also, several Golgi protein glycosylation enzymes, including St6galnac2, St8sia4 and st8sia6, are identified using this analysis, suggesting that processing of proteins may be important in regulating BBB formation.

Elucidation of the Set of BBB-Enriched Transporters {#s3d}
---------------------------------------------------

Another key aspect of the blood-brain barrier is the expression of transporters by CNS endothelial cells. Whereas many transporters have already been identified as highly enriched at the BBB, a genome wide analysis has not been performed before. In [Table 4](#pone-0013741-t004){ref-type="table"} we present a list of transporters expressed by the CNS vasculature. We divide these into four categories: BBB enriched transporters which are enriched in CNS endothelial cells compared with peripheral endothelial cells; pan-endothelial transporters identified in all endothelial cells analyzed; pericyte enriched transporters ([Table 4](#pone-0013741-t004){ref-type="table"}); and ubiquitous transporters expressed by all cells analyzed (data not shown). Elucidating the substrates of these transporters may provide a greater understanding of how endothelial cells participate in the metabolic division of labor within the CNS. Furthermore, these transporters may be utilized to target specific molecules for delivery into the brain for therapeutic purposes.

10.1371/journal.pone.0013741.t004

###### Transporters of the BBB.
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  A.Probe set ID    Gene Symbol   Brain GFP+   Liver GFP+   Lung GFP+   B.Probe set ID   Gene Symbol   Brain GFP+   Liver GFP+   Lung GFP+
  ---------------- ------------- ------------ ------------ ----------- ---------------- ------------- ------------ ------------ -----------
  1433933_s\_at       Slco2b1       7798.5        34.4        420.7     1439368_a\_at     Slc9a3r2      11220.0       5884.7      9141.2
  1423343_at          Slco1c1      30482.2        17.5        98.3      1438559_x\_at      Slc44a2       7412.4      30206.2      17458.8
  1420405_at          Slco1a4      38443.9        45.4        85.4        1433645_at       Slc44a1       8029.7       5969.1      5828.9
  1418326_at          Slc7a5       13681.2       866.3        18.6      1425364_a\_at      Slc3a2       18715.9       8790.5      12701.4
  1417022_at          Slc7a3        2336.3        60.5        70.8        1416832_at       Slc39a8      11166.0      16155.8      1380.6
  1454991_at          Slc7a1       31330.8       696.7       2873.3       1429593_at       Slc38a2       3477.9       2701.2      3444.1
  1437149_at          Slc6a6       21228.3       1608.7      6912.5       1452059_at       Slc35f5       1790.0       1341.4      2176.9
  1436137_at          Slc6a17       243.6        114.6        98.1        1453300_at       Slc35d2       1199.2       912.8        421.2
  1451486_at          Slc46a3       2002.6       343.5        392.6       1433898_at      Slc25a30       1114.3       1358.5       556.7
  1447227_at          Slc40a1       953.7        116.1        22.8        1424735_at      Slc25a25       677.4        578.3        766.9
  1433751_at         Slc39a10      36219.1       1987.1      3932.0       1452717_at      Slc25a24       3275.4       2221.4      2520.1
  1454622_at          Slc38a5       5337.6        22.5        396.4       1450395_at       Slc22a5       2034.3       1478.3      1606.7
  1418706_at          Slc38a3       8758.2       102.4        10.7        1429726_at       Slc16a9       6134.7       164.5       4913.5
  1429154_at          Slc35f2       3223.2        5.8         46.6        1418257_at       Slc12a7       1271.8       1519.8      2671.3
  1433750_at          Slc31a1       3655.1       1091.9       953.6     1451227_a\_at      Slc10a3       1095.1       1157.3       620.5
  1436164_at          Slc30a1      23687.8       3827.4      4884.1     1418774_a\_at       Atp7a        2948.3       2002.4      3669.4
  1434773_a\_at       Slc2a1       41376.6       267.8       1419.6       1442145_at       Atp13a3       534.7        250.3       2057.8
  1424211_at         Slc25a33       936.5        332.8        188.8       1455083_at       Atp11c        4660.2       3234.7      3048.5
  1453149_at         Slc25a32       1131.7       368.3        253.8     1451388_a\_at      Atp11b        5863.6       1539.2      2495.8
  1423109_s\_at      Slc25a20       1082.6       408.0        515.9       1436544_at       Atp10d        3373.8       1319.2      2658.9
  1435418_at          Slc22a8       9605.2        12.4        12.6                                                              
  1448299_at          Slc1a1        8321.1        61.9        521.2                                                             
  1436417_at          Slc19a3       9686.6        38.8        91.6                                                              
  1426082_a\_at       Slc16a4       1724.0        18.3        50.8                                                              
  1418445_at          Slc16a2       3708.5       689.0        232.1                                                             
  1415802_at          Slc16a1      32259.1       544.3        217.5                                                             
  1447851_x\_at       Atp10a       16691.2        52.4        676.0                                                             
  1422906_at           Abcg2       24521.4       2038.1      4007.5                                                             
  1443870_at           Abcc4       17102.3       2475.8       872.6                                                             
  1419759_at          Abcb1a       42011.6       129.7       3931.4                                                             

  C.Probe Set ID    Gene Symbol   Brain Vascular   Brain Endothelial   Vascular/Endothelial              
  ---------------- ------------- ---------------- ------------------- ---------------------- -- -- -- -- --
  1448918_at          Slco3a1         474.1              36.3                  13.1                      
  1438751_at         Slc30a10         824.0              42.1                  19.6                      
  1448132_at          Slc19a1         1108.0             86.4                  12.8                      
  1417622_at          Slc12a2         8112.9            2419.8                 3.4                       
  1421129_a\_at       Atp2a3          1456.1             652.0                 2.2                       
  1435148_at          Atp1b2          1477.6             247.5                 6.0                       
  1434893_at          Atp1a2          2744.3             221.9                 12.4                      
  1436411_at          Atp13a5         5209.0             260.3                 20.0                      
  1435751_at           Abcc9          7314.9             448.6                 16.3                      
  1440879_at           Abca9          630.6              53.0                  11.9                      

A\) BBB enriched transporters. Transporters from the Slc, Slco, ATP and Abc gene families with enriched expression in brain endothelial cells. Transporters identified in [Table S6](#pone.0013741.s006){ref-type="supplementary-material"}, all of which have at least a two-fold greater expression value in brain GFP^+^ than liver and lung GFP^+^ cells, pericyte genes excluded.

B\) Endothelial transporters. Transporters expressed in multiple endothelial samples. These transporters were identified as endothelial specific in [Table S2](#pone.0013741.s002){ref-type="supplementary-material"}, but were not significantly enriched in brain GFP^+^ cells compared to either the liver GFP^+^ or lung GFP^+^ samples.

C\) Pericyte enriched transporters. A list of pericyte enriched transporters from [Table S3](#pone.0013741.s003){ref-type="supplementary-material"}, defined as those transcripts whose GeneChip expression values have a brain vascular:endothelial ratio of ≥2.

Identification of Highly BBB-Enriched Signaling and Metabolic Pathways {#s3e}
----------------------------------------------------------------------

The molecular signals that regulate the formation and function of the BBB remain largely unknown. We therefore took advantage of Ingenuity Pathway Analysis (IPA) software to analyze the CNS endothelial enriched transcripts to identify signaling pathways that are enriched at the BBB or in peripheral endothelial cells ([Table 5a,c](#pone-0013741-t005){ref-type="table"}). We identified several pathways as being significantly associated with brain endothelial cells, including the Wnt/beta-catenin signaling pathway[@pone.0013741-Daneman1]. This pathway has been demonstrated to be specifically activated in CNS endothelial cells, and is important for regulating CNS-specific angiogenesis and inducing BBB properties including the expression of glut-1 and tight junction proteins[@pone.0013741-Daneman1], [@pone.0013741-Liebner1], [@pone.0013741-Stenman1]. The identification of the BBB inducing Wnt pathway validates this database as a method to identify pathways that may be important for BBB formation.

10.1371/journal.pone.0013741.t005

###### Signaling cascades and metabolic pathways enriched at the BBB and peripheral endothelial cells.
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  A.BBB enriched signaling pathway                                        P-value           B.BBB enriched metabolic pathway           P-value
  ---------------------------------------------------------------------- ---------- ------------------------------------------------- ---------
  LPS/IL-1 Mediated Inhibition of RXR Function                            1.20E-05   Glycosphingolipid Biosynthesis - Neolactoseries    0.004
  Serotonin Receptor Signaling                                             0.001        Glycine, Serine and Threonine Metabolism        0.008
  Clathrin-mediated Endocytosis Signaling                                  0.003                Phenylalanine Metabolism                0.010
  Dopamine Receptor Signaling                                              0.008                   Nitrogen Metabolism                  0.025
  PXR/RXR Activation                                                       0.025               Glycolysis/Gluconeogenesis               0.027
  Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes     0.039       Synthesis and Degradation of Ketone Bodies       0.031
  Role of Wnt/GSK-3beta Signaling in the Pathogenesis of Influenza         0.039                  Histidine Metabolism                  0.035
  Wnt/beta-catenin Signaling                                               0.040                  Methionine Metabolism                 0.035
  Type II Diabetes Mellitus Signaling                                      0.049                                                      

  C.Peripheral enriched signaling pathway                                P-value    D.Peripheral enriched metabolic athway   P-value
  --------------------------------------------------------------------- ---------- ---------------------------------------- ---------
  Hepatic Fibrosis / Hepatic Stellate Cell Activation                    1.60E-07          Sphingolipid Metabolism            0.044
  Dendritic Cell Maturation                                              3.40E-06                                           
  Type I Diabetes Mellitus Signaling                                     1.20E-05                                           
  Atherosclerosis Signaling                                              1.30E-04                                           
  Hepatic Cholestasis                                                    3.50E-04                                           
  Complement System                                                      3.70E-04                                           
  Molecular Mechanisms of Cancer                                         6.80E-04                                           
  Acute Phase Response Signaling                                          0.001                                             
  Caveolar-mediated Endocytosis Signaling                                 0.001                                             
  Role of Osteoblasts, Osteoclasts and Chondrocytes in Arthritis          0.001                                             
  Death Receptor Signaling                                                0.001                                             
  Production of NO and Reactive Oxygen Species in Macrophages             0.002                                             
  IL-10 Signaling                                                         0.002                                             
  TNFR1 Signaling                                                         0.002                                             
  Macropinocytosis Signaling                                              0.002                                             
  Leukocyte Extravasation Signaling                                       0.003                                             
  Apoptosis Signaling                                                     0.003                                             
  Role of Macrophages, Fibroblasts and Endothelial Cells in Arthritis     0.003                                             
  IL-8 Signaling                                                          0.003                                             
  NF-κB Signaling                                                         0.003                                             
  Antigen Presentation Pathway                                            0.003                                             
  Integrin Signaling                                                      0.004                                             
  LPS/IL-1 Mediated Inhibition of RXR Function                            0.004                                             
  p53 Signaling                                                           0.004                                             
  Glioma Invasiveness Signaling                                           0.004                                             
  HER-2 Signaling in Breast Cancer                                        0.006                                             
  VDR/RXR Activation                                                      0.007                                             
  Colorectal Cancer Metastasis Signaling                                  0.008                                             
  Graft-versus-Host Disease Signaling                                     0.009                                             
  Altered T Cell and B Cell Signaling in Rheumatoid Arthritis             0.011                                             
  IL-9 Signaling                                                          0.011                                             
  Virus Entry via Endocytic Pathways                                      0.012                                             
  TWEAK Signaling                                                         0.014                                             
  LXR/RXR Activation                                                      0.014                                             
  Aryl Hydrocarbon Receptor Signaling                                     0.015                                             
  HMGB1 Signaling                                                         0.017                                             
  Airway Pathology in Chronic Obstructive Pulmonary Disease               0.021                                             
  Endothelin-1 Signaling                                                  0.023                                             
  Docosahexaenoic Acid (DHA) Signaling                                    0.023                                             
  Cholecystokinin/Gastrin-mediated Signaling                              0.024                                             
  Induction of Apoptosis by HIV1                                          0.027                                             
  Role of PKR in Interferon Induction and Antiviral Response              0.028                                             
  Germ Cell-Sertoli Cell Junction Signaling                               0.029                                             
  CXCR4 Signaling                                                         0.031                                             
  Sphingosine-1-phosphate Signaling                                       0.032                                             
  Retinoic acid Mediated Apoptosis Signaling                              0.033                                             
  GM-CSF Signaling                                                        0.033                                             
  IL-12 Signaling and Production in Macrophages                           0.040                                             
  Allograft Rejection Signaling                                           0.040                                             
  TNFR2 Signaling                                                         0.046                                             
  Autoimmune Thyroid Disease Signaling                                    0.046                                             
  T Helper Cell Differentiation                                           0.049                                             
  Toll-like Receptor Signaling                                            0.049                                             

A--B) BBB enriched pathways. Ingenuity Pathway Analysis (IPA) software was utilized to identify signaling cascades (A) and metabolic pathways (B) that are significantly enriched at the BBB. For this analysis BBB enriched transcripts identified in [Table S6](#pone.0013741.s006){ref-type="supplementary-material"} were utilized. Pathways in which p-value \<0.05 are displayed.

C--D) Peripheral vascular enriched pathways. IPA software was utilized to identify signaling cascades (C) and metabolic pathways (D) that are significantly enriched in peripheral vessels compared to brain vessels. For this analysis peripheral enriched transcripts identified in [Table S7](#pone.0013741.s007){ref-type="supplementary-material"} were utilized. Pathways in which p-value \<0.05 are displayed.

The "LPS/IL-1 mediated inhibition of retinoic x receptor (RXR) function" pathway was enriched with the highest confidence level in the CNS endothelial cells compared with liver and lung endothelial cells. The core of this pathway is a transcriptional cassette activated by the nuclear receptor RXRalpha, which can also be inhibited by a cytoplasmic kinase cascade initiated by LPS, IL-1 or TNFalpha signals. Many transcripts whose expression is turned on by RXRalpha are specifically expressed by CNS endothelial cells. These transcripts include Oatp2, Mrp4, Mdr1, Aldh, Pltp, Cpt, Hmgcs and Alas1, some of which are BBB enriched transporters presented in [Table 4](#pone-0013741-t004){ref-type="table"}. Remarkably, the "LPS/IL-1 mediated inhibition of RXR function" pathway is also enriched in peripheral endothelial cells compared with brain endothelial cells. However, the transcripts enriched in peripheral endothelial cells encode molecules which inhibit RXRalpha function, including secreted molecules, membrane receptors and cytoplasmic signaling components (Lbp, IL-1, Cd14, Myd6b, Nfp). This suggests that a fundamental difference between CNS and peripheral endothelial cells is that RXRalpha mediated transcription is activated in CNS endothelial cells and inhibited in peripheral endothelial cells. In addition we have identified that neurotransmitter signaling, regulation of IL-2, and other pathways are enriched in brain endothelial cells. These findings strongly suggest in addition to Wnt signaling, RXRalpha, and other signaling may impart BBB specific properties to CNS endothelial cells.

IPA software was also used to identify metabolic pathways enriched at the BBB or in peripheral endothelial cells ([Table 5b,d](#pone-0013741-t005){ref-type="table"}). Glycolysis/gluconeogenesis and amino acid metabolism are enriched at the BBB, suggesting that brain endothelial cells may be intimately involved in the production of energy metabolites and amino acids for neurons, a function that has been thought to be uniquely served by astrocytes.

Prediction of Novel Cell-Cell Signaling Interactions Between Vascular and Parenchymal Cell Types {#s3f}
------------------------------------------------------------------------------------------------

From the endothelial and pericyte transcriptome data sets, we next generated predictions about the molecular nature of the cell-cell interactions by which endothelial cells and pericytes communicate. These interactions may be critical for vascular contraction, remodeling, differentiation, and permeability. In fact of the top 50 pericyte enriched genes, 40 are predicted by David Bionformatics or Mouse Genome Informatics (MGI) to encode transmembrane or secreted proteins, and thus are potentially important for endothelial-pericyte signaling. Using this analysis we identified previously known endothelial-pericyte signals, thus validating this approach. For instance, endothelial secreted PDGF-BB regulates the proliferation and survival of CNS pericytes through PDGFRbeta as evidenced by the complete lack of CNS pericytes in PDGFB or PDGFRbeta deficient mice [@pone.0013741-Lindahl1], [@pone.0013741-Lindahl2]. In our data set, PDGFB is enriched in endothelial cells whereas PDGFRbeta is specifically expressed by pericytes. Other potential endothelial-to-pericyte signals include endothelial-derived Jagged2 or Dll4 activation of pericyte-expressed Notch3, or endothelial-derived sema3c, sema3g, sema4c and sema7a signaling to pericyte-expressed plexin B2, Plxdc1 and Plxdc2. Putative pericyte-to-endothelial signals include pericyte derived TGFbeta superfamily members bmp5 and nodal, and endothelial cell expressed activin receptors (Acvr1, Acvrl1) and bmp receptors (Bmpr2). In addition we identified angiotensin I converting enzyme 2 (Ace2) as highly expressed by pericytes, and thus likely to be involved in generating ligands for agtrl1 receptors made by endothelial cells. These ligand-receptor pairs are thus candidates to play important roles in brain angiogenesis and BBB development.

We further looked for novel vascular-parenchymal cell interactions. Recent work suggests that neural-vascular cellular interactions are important for the development of the nervous system. Comparing the vascular enriched genes with those expressed by neurons and glia [@pone.0013741-Cahoy1] can lead to the discovery of signaling pathways important for the development of the CNS. Astrocytes possess long processes whose endfeet ensheath blood vessels. This close association has been implicated in regulating angiogenesis, vascular contraction and blood-brain barrier permeability [@pone.0013741-Abbott1]. Among astrocyte enriched genes defined by Cahoy et al (2008), 798 of 2618 are predicted by DAVID bioinformatics to be membrane or secreted. Of these, many have putative receptors expressed by endothelial cells. For instance putative astrocytes/endothelial interactions may be mediated through ApoE/Lrp8; BMP7/ActrIIa; AGT/Agtrl1; Wnt7a,Wnt7b/Fzd4,Fzd6; ang1/tie-2, and VEGFa/Flt1, Flt, Kdr. Blood vessels also interact with neural stem cells in the developing and adult nervous system, providing a "vascular niche" that maintains stem cells, promotes their division, and expands neurogenesis [@pone.0013741-Shen1]. Along these lines, we identified a high level of expression of potential oligodendrocyte precursor cell (OPC) mitogens within endothelial cells including cxcl12/sdf1, kitl, csf1, and PDGFB, with cognate receptors being highly expressed by OPCs, respectively cmkor1/cxcr7, c-kit, csf1r, and PDGFRalpha [@pone.0013741-Maysami1], [@pone.0013741-Ida1], [@pone.0013741-Pringle1], [@pone.0013741-Sawada1].

Developmental Changes in BBB Gene Expression {#s3g}
--------------------------------------------

In order to understand developmental changes that regulate angiogenesis and formation of the BBB, we used FACS to purify and then profile vascular cells (GFP^+^) from the cerebral cortex of Tie2GFP mice of different ages. We compared cells purified from postnatal (P2--8) mice and adult (p60--70) mice. In [Table S4](#pone.0013741.s004){ref-type="supplementary-material"} and [Table S5](#pone.0013741.s005){ref-type="supplementary-material"} we list the CNS vascular transcripts significantly up-regulated and down-regulated during development from postnatal to adult mice, and in [Table 6](#pone-0013741-t006){ref-type="table"} we list the signaling cascades and metabolic pathways identified by IPA that significantly change during development. Interestingly, Interferon, Prolactin, Growth Hormone, and circadian rhythm signaling are significantly up-regulated during development suggesting these pathways may regulate the maturation of the vasculature. On the other hand, integrin signaling, protein ubiquitination and hypoxia signaling are all down-regulated during development suggesting that these pathways may be involved in regulating angiogenesis.

10.1371/journal.pone.0013741.t006

###### Developmentally regulated brain endothelial signaling cascades and metabolic pathways.

![](pone.0013741.t006){#pone-0013741-t006-6}

  A.Up-regulated Signaling Pathway                                       P-value                C.Down-regulated Signaling Pathway                P-value
  --------------------------------------------------------------------- ---------- ------------------------------------------------------------- ----------
  Interferon Signaling                                                   1.60E-04                    Mitochondrial Dysfunction                    4.50E-05
  Prolactin Signaling                                                    3.90E-04    Airway Pathology in Chronic Obstructive Pulmonary Disease     0.004
  Growth Hormone Signaling                                                0.001                            RAN Signaling                           0.004
  Circadian Rhythm Signaling                                              0.001                       Parkinson\'s Signaling                       0.006
  Synaptic Long Term Potentiation                                         0.003                  Sphingosine-1-phosphate Signaling                 0.006
  Phospholipase C Signaling                                               0.005                   Molecular Mechanisms of Cancer                   0.007
  IL-3 Signaling                                                          0.007                       Endothelin-1 Signaling                       0.007
  Cholecystokinin/Gastrin-mediated Signaling                              0.007                         Integrin Signaling                         0.010
  Factors Promoting Cardiogenesis in Vertebrates                          0.008                         Apoptosis Signaling                        0.011
  Renin-Angiotensin Signaling                                             0.009               Regulation of eIF4 and p70S6K Signaling              0.017
  Molecular Mechanisms of Cancer                                          0.009                          p70S6K Signaling                          0.017
  NRF2-mediated Oxidative Stress Response                                 0.010            Cell Cycle Regulation by BTG Family Proteins            0.018
  GNRH Signaling                                                          0.011                           mTOR Signaling                           0.018
  JAK/Stat Signaling                                                      0.011                   Protein Ubiquitination Pathway                   0.019
  IGF-1 Signaling                                                         0.012      Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells     0.029
  Thrombopoietin Signaling                                                0.017                    Glioma Invasiveness Signaling                   0.030
  Huntington\'s Disease Signaling                                         0.017           Hypoxia Signaling in the Cardiovascular System           0.032
  Hypoxia Signaling in the Cardiovascular System                          0.021                           IL-8 Signaling                           0.032
  Role of Macrophages, Fibroblasts and Endothelial Cells in Arthritis     0.025     Production of NO and Reactive Oxygen Species in Macrophages    0.035
  FLT3 Signaling in Hematopoietic Progenitor Cells                        0.026                      Death Receptor Signaling                      0.042
  BMP signaling pathway                                                   0.026                   Induction of Apoptosis by HIV1                   0.045
  EGF Signaling                                                           0.029          Fcγ Receptor-mediated Phagocytosis in Macrophages         0.049
  p53 Signaling                                                           0.030                           HMGB1 Signaling                          0.049
  Glioblastoma Multiforme Signaling                                       0.034                                                                  
  Cardiomyocyte Differentiation via BMP Receptors                         0.035                                                                  
  Endoplasmic Reticulum Stress Pathway                                    0.035                                                                  
  VDR/RXR Activation                                                      0.036                                                                  
  Corticotropin Releasing Hormone Signaling                               0.036                                                                  
  Retinoic acid Mediated Apoptosis Signaling                              0.039                                                                  
  Human Embryonic Stem Cell Pluripotency                                  0.041                                                                  
  p38 MAPK Signaling                                                      0.041                                                                  
  Prostate Cancer Signaling                                               0.044                                                                  
  Ephrin Receptor Signaling                                               0.046                                                                  
  Melanocyte Development and Pigmentation Signaling                       0.046                                                                  
  Aryl Hydrocarbon Receptor Signaling                                     0.046                                                                  
  Oncostatin M Signaling                                                  0.048                                                                  
  CNTF Signaling                                                          0.048                                                                  
  Activation of IRF by Cytosolic Pattern Recognition Receptors            0.048                                                                  
  FGF Signaling                                                           0.049                                                                  

  B.Up-regulated Metabolic Pathway    P-value    D.Down-regulated Metabolic Pathway     P-value
  ---------------------------------- --------- --------------------------------------- ---------
  Riboflavin Metabolism                0.022          Oxidative Phosphorylation          0.001
                                                      Pentose Phosphate Pathway          0.001
                                                         Methane Metabolism              0.004
                                                      Phenylalanine Metabolism           0.004
                                                          Purine Metabolism              0.010
                                                         Lysine Degradation              0.020
                                                Fatty Acid Elongation in Mitochondria    0.036
                                                        N-Glycan Degradation             0.046

A--D) IPA software analysis of developmentally regulated (2-fold up or down) transcripts, identifies signaling cascades (A,C) and metabolic pathways (B,D) that are up-regulated (A,B) or down regulated (C,D) during development. For this analysis developmentally regulated pathways identified in [Table S4](#pone.0013741.s004){ref-type="supplementary-material"} (up-regulated) and [Table S5](#pone.0013741.s005){ref-type="supplementary-material"} (down-regulated) were utilized. Pathways with p-value\<0.05 are listed.

Discussion {#s4}
==========

Identification of the Blood-Brain Barrier Transcriptome {#s4a}
-------------------------------------------------------

In this paper we provide a new resource for understanding gene expression in the developing and adult CNS vasculature. Previous gene profiling studies of brain vessels had several limitations [@pone.0013741-Li1], [@pone.0013741-Li2], [@pone.0013741-Enerson1], [@pone.0013741-Calabria1] including use of whole vessel fractions, which contain many different cell types, and the lack of elucidation of peripheral endothelial profiles for comparison. We have combined FACS purification with GeneChip analysis to generate a transcriptional profile of highly purified endothelial cells from the CNS, and through comparison with liver and lung endothelial cells we have generated a comprehensive list of transcripts enriched at the BBB. These transcripts encode tight junction molecules, transporters, metabolic enzymes, signaling cascades, and proteins of unknown function, that together form the highly specialized interface between the blood and the brain. This represents a novel resource for three reasons. First, we separate CNS endothelial cells from pericytes/VSM, and thus generate a transcriptional profile of endothelial cells, the key cells that form the BBB. Second, we compare brain endothelial cells with peripheral endothelial cells isolated from the liver and lung, identifying transcripts which are specific to barrier forming brain endothelial cells. Finally, we have isolated cells from different ages and thus can identify developmental changes in the BBB. The BBB transcriptome database should be highly useful for understanding the molecular control of CNS angiogenesis, BBB permeability, and the cell-cell interactions in the developing CNS.

Identification of Candidates Transcripts that Control Vascular Permeability {#s4b}
---------------------------------------------------------------------------

A hallmark of the BBB is that CNS endothelial cells are held together by high electrical resistance tight junctions [@pone.0013741-Gloor1], [@pone.0013741-Ueno1]. Of the best characterized tight junction molecules expressed at the BBB, claudin 5, occludin, ZO-1 and ZO-2, only occludin is specifically expressed at the blood-brain barrier and not by non-barrier forming vessels [@pone.0013741-Morita1], [@pone.0013741-Hirase1]. The fact that occludin deficient mice still form a functional BBB suggests that the expression of this molecule does not impart BBB function [@pone.0013741-Saitou1]. It therefore remains a mystery as to what causes CNS endothelial cells to form these high electrical resistance tight junctions. In this study we have identified several tight junction molecules whose expression is enriched at the BBB, including marveld2, cingulin-like-1, and pard3, that may play a crucial role in the formation of BBB tight junctions. Our data sets will also be useful to identify novel molecules not previously known to be associated with tight junction proteins, which may be important for BBB integrity. In addition to the highly specialized vasculature of the blood-brain barrier, there is great heterogeneity in the structure and function of vessels in all tissues [@pone.0013741-Aird1], [@pone.0013741-Aird2]. By analyzing the relative levels of transcripts expressed by the endothelial cells in different tissues we can generate hypotheses as to the relevance of different genes for the tissue specific functions of each vessel, including permeability, leukocyte trafficking, hemostasis, angiogenesis, immunity, and vasomotor tone.

Signaling Pathways Enriched at the BBB {#s4c}
--------------------------------------

Transplantation experiments have established that the brain environment signals brain endothelial cells to form the BBB [@pone.0013741-Stewart1], but the identity of these signals are largely unknown. In particular, we have identified transcripts from a number of cascades that are enriched in the vasculature of the CNS including Wnt/beta-catenin, RXRalpha and other signaling pathways. The identification of the Wnt pathway, a known BBB inducing signaling pathway, validates this database as a method to identify pathways that may be important for BBB formation.

RXRalpha is a nuclear receptor which activates the transcription of a series of molecules. The activity of RXRalpha can be inhibited by a cytoplasmic kinase cascade initiated by LPS, IL-1 or TNFalpha signals [@pone.0013741-Wang1]. Remarkably, genes in the inhibitory cassette of this pathway, including Lbp, IL-1, Cd14, Myd6b, Nfp are enriched in peripheral endothelial cells, whereas transcripts downstream of RXRalpha are enriched in CNS endothelial cells. Therefore, a fundamental difference between CNS and peripheral endothelial cells is the expression of the RXRalpha transcriptional cassette in CNS endothelial cells, and its suppression in peripheral endothelial cells. RXRalpha is a retinoic acid nuclear receptor which raises the question: Does retinoic acid (RA) regulate the BBB? This seems possible as addition of RA to endothelial cell lines *in vitro* increases the expression of BBB specific molecules Pgp and gamma-glutamyl transpeptidase [@pone.0013741-ElHafny1], [@pone.0013741-Lechardeur1]. This matches our result that many of the RXRalpha regulated transcripts are the BBB enriched transporters, including Oatp2, Mdr1 and Mrp4. Interestingly, this pathway is inhibited by immune system modulating cytokines (IL-1) and bacterial LPS. Perhaps infection and inflammation alter the levels of BBB specific molecules through regulation of RXRalpha activity.

Targeting Tumor Angiogenesis {#s4d}
----------------------------

In addition to identifying novel barrier forming molecules, our data also identifies transcripts that may be important for angiogenesis and/or vascular pathfinding. This is evident as we have identified integrins and semaphorins, both of which have been implicated in the formation of new vessels [@pone.0013741-Proctor1], [@pone.0013741-Gu1], [@pone.0013741-Gu2]. Identifying such molecules may be important for developing treatments for brain tumors, as formation of new vessels is a critical step in tumor progression. Disruption of tumor angiogenesis, without harming mature vessels, is a powerful technique for limiting tumor growth [@pone.0013741-Bertolini1], [@pone.0013741-Noonan1]. To accomplish this, it is key to identify potential targets found on angiogenic vessels, that are absent from mature vessels or parenchymal tissue. In this resource we have identified transcripts whose expression level changes from developmental stages where robust angiogenesis is occurring, to adult animals where angiogenesis is largely completed. Potential targets include prion protein doublet (prnd), madcam1, tachykinin receptor 3, Slc7a8, and Cxcr4. Each of these transcripts is enriched in postnatal brain endothelial cells as compared with adult brain, liver and lung endothelial cells, and adult CNS parenchyma.

In summary, we have generated a comprehensive data set describing the transcriptome of the BBB. This will provide a valuable resource for understanding the development and function of this crucial barrier, as well as its role modulating CNS function.

Supporting Information {#s5}
======================

###### 

Complete Excel spreadsheet. The Excel spreadsheet containing the comprehensive list of probe sets from the mouse 430-2 GeneChip, with expression values for adult brain GFP^−^, adult brain GFP^+^, adult brain GFP^+^PDGFRbeta^−^, liver GFP^+^, lung GFP^+^, and postnatal brain GFP^+^ samples. Each expression value is the average of at least three biological replicates.

(9.96 MB XLS)

###### 

Click here for additional data file.

###### 

Endothelial specific genes. A data set containing probe sets from the mouse 430--2 GeneChip statistically enriched in CNS endothelial cells compared with CNS parenchyma as identified by probe sets with GFP^+^PDGFRbeta^−^:GFP^−^ \>2 with expression value in GFP^+^PDGFRbeta^−^\>200. SAM algorithms were utilized to identify significance.

(0.87 MB XLS)

###### 

Click here for additional data file.

###### 

Pericyte specific genes. A data set containing probe sets from the mouse 430--2 GeneChip statistically enriched in CNS pericytes compared with CNS endothelial cells as identified by probe sets with GFP^+^:GFP^+^PDGFRbeta^−^\>2 with expression value in GFP^+^\>200. SAM algorithms were utilized to identify significance.

(0.10 MB XLS)

###### 

Click here for additional data file.

###### 

Developmentally up-regulated CNS vascular genes. A data set containing probe sets from the mouse 430--2 GeneChip statistically up-regulated in CNS vessels during development as identified by probe sets with adult GFP^+^:postnatal\>2 with expression value in adult GFP^+^\>200. Pericyte genes were eliminated from this dataset. SAM algorithms were utilized to identify significance.

(0.43 MB XLS)

###### 

Click here for additional data file.

###### 

Developmentally down-regulated CNS vascular genes. A data set containing probe sets from the mouse 430--2 GeneChip statistically down-regulated in CNS vessels during development as identified by probe sets with adult GFP^+^:postnatal\<2 with expression value in postnatal GFP^+^\>200. Pericyte genes were eliminated from this dataset. SAM algorithms were utilized to identify significance.

(0.40 MB XLS)

###### 

Click here for additional data file.

###### 

BBB enriched genes. A data set containing probe sets from the mouse 430--2 GeneChip statistically enriched in CNS endothelial cells compared with those from the CNS parenchyma as identified by probe sets with BrainGFP^+^:LiverGFP^+^\>2 and BrainGFP^+^:LungGFP^+^\>2 with expression value in BrainGFP^+^\>200. Additionally separate work sheets are presented for data sets containing BrainGFP^+^:LiverGFP^+^\>2 with expression value in BrainGFP^+^\>200, and BrainGFP^+^:LungGFP^+^\>2 with expression value in BrainGFP^+^\>200. Pericyte genes were eliminated from each dataset. SAM algorithms were utilized to identify significance.

(1.01 MB XLS)

###### 

Click here for additional data file.

###### 

Peripheral endothelial enriched genes. A data set containing probe sets from the mouse 430--2 GeneChip statistically enriched in peripheral endothelial cells compared with those from the CNS as identified by probe sets with LiverGFP^+^:BrainGFP^+^ \>2 and LungGFP^+^:BrainGFP^+^ \>2 with expression value in LiverGFP^+^\>200 and LungGFP^+^\>200. SAM algorithms were utilized to identify significance.

(0.28 MB XLS)

###### 

Click here for additional data file.
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